Healing Hope: A Gel Derived From Blood : There is a gel that is made from a patient’s blood that can drastically speed the healing process of chronic wounds, especially ulcers that occur on the feet of diabetic patients. When these ulcers are treated with the gel they are far more likely to have a healthy… Read More: Healing Hope: A Gel Derived From Blood »
SAN FRANCISCO—After agreeing last year to swallow Celgene for a whopping $ 74 billion, Bristol-Myers Squibb trumpeted the potential of pairing its solid-tumor expertise with Celgene’s hematology expertise to create a leading cancer drugmaker. But the legacy BMS business had some hematology expertise of its own—and Celgene’s taking advantage, said Nadim Ahmed, the now-combined company’s… Read More: Celgene taps Bristol-Myers salesforce to bolster key blood cancer launches »
As much as we try to avoid having our babies go through pain, sometimes it is inevitable — and sometimes, as is the case with vaccinations and blood tests, pain is part of something that is ultimately important for the baby’s health and well-being. Luckily, shots and blood tests are both quick. But there are… Read More: How to help your baby through shots and blood tests »
FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in Adults With Beta Thalassemia Who Require Regular Red Blood Cell Transfusions Print this page SUMMIT, N.J. & CAMBRIDGE, Mass.–(BUSINESS WIRE)– Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced the U.S. Food and Drug Administration (FDA) has approved Reblozyl (luspatercept-aamt) for the… Read More: FDA Approves Reblozyl (luspatercept-aamt) for the Treatment of Anemia in… »